Idiopathic thrombocytopenic purpura
Clinical trials for Idiopathic thrombocytopenic purpura explained in plain language.
Never miss a new study
Get alerted when new Idiopathic thrombocytopenic purpura trials appear
Sign up with your email to follow new studies for Idiopathic thrombocytopenic purpura, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug calm the immune System's attack on blood cells?
Disease control CompletedThis study is testing an experimental drug called povetacicept in adults with autoimmune cytopenias — conditions where the immune system mistakenly destroys blood cells, leading to low platelet counts (immune thrombocytopenia) or anemia (autoimmune hemolytic anemia and cold agglu…
Matched conditions: IDIOPATHIC THROMBOCYTOPENIC PURPURA
Phase 1/2 • Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New hope for ITP patients: drug boosts platelet counts in early study
Disease control CompletedThis study tested a drug called lusutrombopag in 17 Chinese adults with persistent or chronic immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. Participants had failed standard treatments and took the drug for up to 12 w…
Matched conditions: IDIOPATHIC THROMBOCYTOPENIC PURPURA
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC